Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Dere, W*" or (type exact bookEditor and editor="Dere, W*")

Add to list
Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data: an expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Cyrus Cooper, Thomas Bardin, Maria-Luisa Brandi, Patrice Cacoub, John Caminis, Roberto Civitelli, Maurizio Cutolo, Willard Dere, Jean-Pierre Devogelaer, Adolfo Diez-Perez, et al.

(2016) AGING CLINICAL AND EXPERIMENTAL RESEARCH. 28(1). p.1-16
Add to list
Treatment of osteoporosis in men

Jean Kaufman (UGent) , J-Y Reginster, S Boonen, ML Brandi, C Cooper, W Dere, J-P Devogelaer, A Diez-Perez, JA Kanis, E McCloskey, et al.

(2013) BONE. 53(1). p.134-144
Add to list
Frailty and sarcopenia: definitions and outcome parameters

C Cooper, W Dere, W Evans, JA Kanis, R Rizzoli, AA Sayer, CC Sieber, Jean Kaufman (UGent) , G Abellan van Kan, S Boonen, et al.

(2012) OSTEOPOROSIS INTERNATIONAL. 23(7). p.1839-1848
Add to list
The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)

O Bruyere, JA Kanis, ME Ibar-Abadie, N Alsayed, ML Brandi, N Burlet, DL Cahall, A Chines, JP Devogelaer, W Dere, et al.

(2010) OSTEOPOROSIS INTERNATIONAL. 21(5). p.713-722
Add to list
- Miscellaneous
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men

JY REGINSTER, E ABADIE, P DELMAS, R RIZZOLI, W DERE, P DER AUWERA, B AVOUAC, ML BRANDI, A DAIFOTIS, A DIEZ-PEREZ, et al.

(2006) OSTEOPOROSIS INTERNATIONAL. 17(1). p.1-7

Academic Bibliography

Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data: an expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Treatment of osteoporosis in men

Frailty and sarcopenia: definitions and outcome parameters

The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)

Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men

Contents

Support

Contact